More recently, FHIT was identified as a potentially clinically relevant BMPR2 modifier gene through an siRNA screen of BMPR2 signaling regulatory genes combined with publicly available PAH RNA expression data. Here, BMPR2 is linked to pulmonary arterial hypertension.